Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Net Income (2016 - 2017)

Tenax Therapeutics' Net Income history spans 8 years, with the latest figure at -$17.0 million for Q4 2017.

  • For Q4 2017, Net Income rose 71.41% year-over-year to -$17.0 million; the TTM value through Dec 2017 reached -$9.2 million, up 87.63%, while the annual FY2025 figure was -$52.6 million, 198.62% down from the prior year.
  • Net Income for Q4 2017 was -$17.0 million at Tenax Therapeutics, down from $1.3 million in the prior quarter.
  • Across five years, Net Income topped out at $3.5 million in Q1 2017 and bottomed at -$59.6 million in Q4 2016.
  • The 5-year median for Net Income is -$4.7 million (2016), against an average of -$11.1 million.
  • The largest annual shift saw Net Income crashed 105.91% in 2013 before it skyrocketed 164.53% in 2017.
  • A 5-year view of Net Income shows it stood at -$2.4 million in 2013, then crashed by 414.91% to -$12.4 million in 2014, then plummeted by 89.11% to -$23.5 million in 2015, then plummeted by 153.47% to -$59.6 million in 2016, then surged by 71.41% to -$17.0 million in 2017.
  • Per Business Quant, the three most recent readings for TENX's Net Income are -$17.0 million (Q4 2017), $1.3 million (Q3 2017), and $3.0 million (Q2 2017).